Metformin therapy and its anti-neoplastic role in systemic malignancies besides hepatocellular carcinomas
作者： S Kapoor
DOI: 10.3109/00365521.2013.777773
关键词: Oncology 、 Metformin 、 Internal medicine 、 Carcinogenesis 、 Medicine 、 Anti neoplastic
摘要: To the Editor: I read with great interest recent article written by Zhang et al. [1]. Suggest that metformin may play a major role in mitigating carcinogenesis as well enhancing effic...
informahealthcare.com参考文章(11)
Lingling Dong, Qian Zhou, Zhenbo Zhang, Yaping Zhu, Tao Duan, Youji Feng, Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression Journal of Obstetrics and Gynaecology Research. ,vol. 38, pp. 1077- 1085 ,(2012) , 10.1111/J.1447-0756.2011.01839.X
Jin Ha Lee, Soung Min Jeon, Sung Pil Hong, Jae Hee Cheon, Tae Il Kim, Won Ho Kim, Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer Digestive and Liver Disease. ,vol. 44, pp. 1042- 1047 ,(2012) , 10.1016/J.DLD.2012.06.007
Xuxian Xiao, Qiongqiong He, Changming Lu, Kaitlin D. Werle, Rui-Xun Zhao, Jianfeng Chen, Ben C. Davis, Rutao Cui, Jiyong Liang, Zhi-Xiang Xu, Metformin impairs the growth of liver kinase B1-intact cervical cancer cells Gynecologic Oncology. ,vol. 127, pp. 249- 255 ,(2012) , 10.1016/J.YGYNO.2012.06.032
Jessica J. Shank, Kun Yang, Jacob Ghannam, Lourdes Cabrera, Carolyn J. Johnston, R. Kevin Reynolds, Ronald J. Buckanovich, Metformin targets ovarian cancer stem cells in vitro and in vivo Gynecologic Oncology. ,vol. 127, pp. 390- 397 ,(2012) , 10.1016/J.YGYNO.2012.07.115
A J Colquhoun, N A Venier, A D Vandersluis, R Besla, L M Sugar, A Kiss, N E Fleshner, M Pollak, L H Klotz, V Venkateswaran, Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer Prostate Cancer and Prostatic Diseases. ,vol. 15, pp. 346- 352 ,(2012) , 10.1038/PCAN.2012.16
BUCHU WU, SHU LI, LILI SHENG, JING ZHU, LIYING GU, HAORAN SHEN, DUANDUAN LA, BRETT D. HAMBLY, SHISAN BAO, WEN DI, Metformin inhibits the development and metastasis of ovarian cancer. Oncology Reports. ,vol. 28, pp. 903- 908 ,(2012) , 10.3892/OR.2012.1890
Hui Zhang, Chun Gao, Long Fang, Hong-Chuan Zhao, Shu-Kun Yao, Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scandinavian Journal of Gastroenterology. ,vol. 48, pp. 78- 87 ,(2013) , 10.3109/00365521.2012.719926
Roongruedee Chaiteerakij, Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Teresa A. Mettler, Zachary S. Fredericksen, W. Ray Kim, Gregory J. Gores, Rosebud O. Roberts, Janet E. Olson, Terry M. Therneau, Lewis R. Roberts, Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk Hepatology. ,vol. 57, pp. 648- 655 ,(2013) , 10.1002/HEP.26092
Peter J Mazzone, Hardeep Rai, Mary Beukemann, Meng Xu, Anil Jain, Madhu Sasidhar, The effect of metformin and thiazolidinedione use on lung cancer in diabetics BMC Cancer. ,vol. 12, pp. 410- 410 ,(2012) , 10.1186/1471-2407-12-410
Daniel K Chan, W Miskimins, Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures Journal of Ovarian Research. ,vol. 5, pp. 19- 19 ,(2012) , 10.1186/1757-2215-5-19